Lexeo Therapeutics (LXEO) Non Operating Investment Income (2025 - 2026)
Lexeo Therapeutics (LXEO) reported Non Operating Investment Income of -$330000.0 for Q1 2026, down 773.47% on a YoY basis from $49000.0 in Q1 2025, and down 904.88% sequentially from $41000.0 in Q2 2025.
Lexeo Therapeutics (LXEO) Non Operating Investment Income (2025 - 2026) Analysis & Trends
Lexeo Therapeutics (LXEO) has 2 years of Non Operating Investment Income data on file, last reported at -$330000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Lexeo Therapeutics | 379.94 Mn | 379.94 Mn | - | -330,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -330,000.00 |
| Mar 31, 2026 | -330,000.00 |
| Jun 30, 2025 | 41,000.00 |
| Jun 30, 2025 | 41,000.00 |
| Mar 31, 2025 | 49,000.00 |
| Mar 31, 2025 | 49,000.00 |